author-photo

Ellen Chuang

Cornell University

32

Papers

1201

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (80)
Clinical and Translational Results of a Phase II, Randomized Trial of an AntiIGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

2016 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (37)
Phase I clinical trial of ixabepilone and pegylated liposomal doxorubicin in patients with advanced breast or ovarian cancers: New York Cancer Consortium Trial P7229

2016 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
Dual light field and polarization imaging using CMOS diffractive image sensors

2015 Optics Letters
Show All
- Source
- Cite
- Save
Citations (9)
Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

2015 BMC Cancer
Show All
- Source
- Cite
- Save
Citations (42)
Abstract P5-19-08: IMMU-132, a potential new antibody-drug conjugate (ADC) for the treatment of triple-negative breast cancer (TNBC): Preclinical and initial clinical results

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract P5-19-27: IMMU-132, a new antibody-drug conjugate (ADC) against Trop-2, as a novel therapeutic for patients with relapsed/refractory, metastatic, triple-negative breast cancer (TNBC): Results from Phase I/II clinical trial (NCT01631552)

2015 Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2-positive breast cancer.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

2014 Science Translational Medicine
Show All
- Source
- Cite
- Save
Citations (225)
Abstract CT309: Influencing the tumor microenvironment: A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)